Fund shareholders of 4D Molecular Therapeutics Inc
ISIN US35104E1001 · United States
- Fund shareholders
- 163
- Of which ETFs
- 33 130 other funds
- Value held
- 109.5M $
| Fund | Shares | Value | Weight in fund | |
|---|---|---|---|---|
| SA Small Cap Index Portfolio SUNAMERICA SERIES TRUST | 4,300 | 38.1K $ | 0.01 % | as of Apr 30, 2026 ↗ |
| Innovator U.S. Small Cap Managed Floor ETF Innovator ETFs Trust | 4,239 | 37.6K $ | 0.05 % | as of Apr 30, 2026 ↗ |
| U.S. CORE EQUITY 1 PORTFOLIO DFA INVESTMENT DIMENSIONS GROUP INC | 3,893 | 34.5K $ | 0.00 % | as of Apr 30, 2026 ↗ |
| iShares Total U.S. Stock Market Index Fund BlackRock Funds | 3,771 | 33.4K $ | 0.00 % | as of Apr 30, 2026 ↗ |
| Nationwide Small Cap Index Fund Nationwide Mutual Funds | 3,766 | 33.4K $ | 0.01 % | as of Apr 30, 2026 ↗ |
| AST Small-Cap Equity Portfolio Advanced Series Trust | 3,640 | 33.9K $ | 0.00 % | as of Mar 31, 2026 ↗ |
| PD Small-Cap Value Index Portfolio PACIFIC SELECT FUND | 3,635 | 33.8K $ | 0.03 % | as of Mar 31, 2026 ↗ |
| VANGUARD RUSSELL 3000 INDEX FUND VANGUARD SCOTTSDALE FUNDS | 3,503 | 33.8K $ | 0.00 % | as of Feb 28, 2026 ↗ |
| CVT Russell 2000 Small Cap Index Portfolio Calvert Variable Trust, Inc. | 3,355 | 31.2K $ | 0.01 % | as of Mar 31, 2026 ↗ |
| Invesco Nasdaq Biotechnology ETF Invesco Exchange-Traded Fund Trust II | 3,185 | 30.8K $ | 0.04 % | as of Feb 28, 2026 ↗ |
| Dimensional US Core Equity 1 ETF Dimensional ETF Trust | 3,158 | 28K $ | 0.00 % | as of Apr 30, 2026 ↗ |
| THRIVENT MODERATELY AGGRESSIVE ALLOCATION PORTFOLIO Thrivent Series Fund, Inc. | 3,121 | 29.1K $ | 0.00 % | as of Mar 31, 2026 ↗ |
| Strategic Equity Allocation Trust John Hancock Variable Insurance Trust | 3,105 | 28.9K $ | 0.00 % | as of Mar 31, 2026 ↗ |
| Venerable Small Cap Index Fund Venerable Variable Insurance Trust | 3,059 | 28.5K $ | 0.01 % | as of Mar 31, 2026 ↗ |
| LVIP Dimensional U.S. Core Equity 1 Fund LINCOLN VARIABLE INSURANCE PRODUCTS TRUST | 2,900 | 27K $ | 0.00 % | as of Mar 31, 2026 ↗ |
| VIP Extended Market Index Portfolio Variable Insurance Products Fund II | 2,790 | 26K $ | 0.01 % | as of Mar 31, 2026 ↗ |
| SA Multi-Managed Small Cap Portfolio SEASONS SERIES TRUST | 2,757 | 25.7K $ | 0.02 % | as of Mar 31, 2026 ↗ |
| Voya VACS Index Series SC Portfolio Voya VARIABLE PORTFOLIOS INC | 2,714 | 25.3K $ | 0.01 % | as of Mar 31, 2026 ↗ |
| ProShares Ultra Nasdaq Biotechnology ProShares Trust | 2,638 | 25.5K $ | 0.03 % | as of Feb 28, 2026 ↗ |
| THRIVENT MODERATE ALLOCATION PORTFOLIO Thrivent Series Fund, Inc. | 2,584 | 24.1K $ | 0.00 % | as of Mar 31, 2026 ↗ |
| ProShares Ultra Russell2000 ProShares Trust | 2,490 | 24.1K $ | 0.01 % | as of Feb 28, 2026 ↗ |
| ProShares UltraPro Russell2000 ProShares Trust | 2,481 | 24K $ | 0.01 % | as of Feb 28, 2026 ↗ |
| JNL/DFA U.S. Core Equity Fund JNL Series Trust | 2,450 | 22.8K $ | 0.00 % | as of Mar 31, 2026 ↗ |
| Avantis Total Equity Markets ETF American Century ETF Trust | 2,361 | 22.8K $ | 0.00 % | as of Feb 28, 2026 ↗ |
| THRIVENT MODERATELY AGGRESSIVE ALLOCATION FUND Thrivent Mutual Funds | 2,148 | 19.1K $ | 0.00 % | as of Apr 30, 2026 ↗ |
| Small-Cap Equity Portfolio PACIFIC SELECT FUND | 1,958 | 18.2K $ | 0.01 % | as of Mar 31, 2026 ↗ |
| Dimensional US Vector Equity ETF Dimensional ETF Trust | 1,918 | 17K $ | 0.00 % | as of Apr 30, 2026 ↗ |
| LVIP Dimensional U.S. Core Equity 2 Fund LINCOLN VARIABLE INSURANCE PRODUCTS TRUST | 1,916 | 17.8K $ | 0.00 % | as of Mar 31, 2026 ↗ |
| Morgan Stanley Pathway Small-Mid Cap Equity ETF MORGAN STANLEY PATHWAY FUNDS | 1,849 | 17.9K $ | 0.00 % | as of Feb 28, 2026 ↗ |
| ProShares Russell 2000 High Income ETF ProShares Trust | 1,740 | 16.8K $ | 0.01 % | as of Feb 28, 2026 ↗ |
| Small Company Value Portfolio Wilshire Mutual Funds Inc | 1,670 | 15.5K $ | 0.07 % | as of Mar 31, 2026 ↗ |
| THRIVENT AGGRESSIVE ALLOCATION FUND Thrivent Mutual Funds | 1,608 | 14.3K $ | 0.00 % | as of Apr 30, 2026 ↗ |
| SmallCap Value Fund II Principal Funds, Inc | 1,441 | 12.8K $ | 0.00 % | as of Apr 30, 2026 ↗ |
| EQ/Franklin Small Cap Value Managed Volatility Portfolio EQ Advisors Trust | 1,398 | 13K $ | 0.01 % | as of Mar 31, 2026 ↗ |
| THRIVENT AGGRESSIVE ALLOCATION PORTFOLIO Thrivent Series Fund, Inc. | 1,359 | 12.7K $ | 0.00 % | as of Mar 31, 2026 ↗ |
| Avantis U.S. Equity Fund American Century ETF Trust | 1,323 | 12.8K $ | 0.00 % | as of Feb 28, 2026 ↗ |
| Nationwide Fundamental All Cap Equity Portfolio Nationwide Mutual Funds | 1,223 | 10.8K $ | 0.00 % | as of Apr 30, 2026 ↗ |
| SA U.S. Small Company Fund SA FUNDS INVESTMENT TRUST | 1,214 | 11.3K $ | 0.00 % | as of Mar 31, 2026 ↗ |
| State Street Total Return V.I.S. Fund STATE STREET VARIABLE INSURANCE SERIES FUNDS INC | 1,096 | 10.2K $ | 0.00 % | as of Mar 31, 2026 ↗ |
| THRIVENT MODERATE ALLOCATION FUND Thrivent Mutual Funds | 1,041 | 9.2K $ | 0.00 % | as of Apr 30, 2026 ↗ |
| VIP Total Market Index Portfolio Variable Insurance Products Fund II | 1,033 | 9.6K $ | 0.00 % | as of Mar 31, 2026 ↗ |
| Penn Series Small Cap Index Fund Penn Series Funds Inc | 1,000 | 9.3K $ | 0.01 % | as of Mar 31, 2026 ↗ |
| Total Stock Market Index Trust John Hancock Variable Insurance Trust | 999 | 9.3K $ | 0.00 % | as of Mar 31, 2026 ↗ |
| Destinations Small-Mid Cap Equity Fund Brinker Capital Destinations Trust | 976 | 9.4K $ | 0.00 % | as of Feb 28, 2026 ↗ |
| THRIVENT GLOBAL STOCK FUND Thrivent Mutual Funds | 934 | 8.3K $ | 0.00 % | as of Apr 30, 2026 ↗ |
| THRIVENT MODERATELY CONSERVATIVE ALLOCATION PORTFOLIO Thrivent Series Fund, Inc. | 880 | 8.2K $ | 0.00 % | as of Mar 31, 2026 ↗ |
| THRIVENT GLOBAL STOCK PORTFOLIO Thrivent Series Fund, Inc. | 774 | 7.2K $ | 0.00 % | as of Mar 31, 2026 ↗ |
| Nuveen Life Stock Index Fund TIAA-CREF Life Funds | 684 | 6.4K $ | 0.00 % | as of Mar 31, 2026 ↗ |
| TIAA Separate Account VA-1 - Stock Index Account TIAA Separate Account VA-1 | 524 | 4.9K $ | 0.00 % | as of Mar 31, 2026 ↗ |
| ULTRA SMALL CAP PROFUND ProFunds | 498 | 4.4K $ | 0.01 % | as of Apr 30, 2026 ↗ |
| State Street Balanced Index Fund STATE STREET INSTITUTIONAL INVESTMENT TRUST | 346 | 3.2K $ | 0.00 % | as of Mar 31, 2026 ↗ |
| Russell 2000 2x Strategy Fund Rydex Dynamic Funds | 205 | 1.9K $ | 0.00 % | as of Mar 31, 2026 ↗ |
| Blackstone Alternative Multi-Strategy Fund Blackstone Alternative Investment Funds | 200 | 1.9K $ | 0.00 % | as of Mar 31, 2026 ↗ |
| THRIVENT MODERATELY CONSERVATIVE ALLOCATION FUND Thrivent Mutual Funds | 150 | 1.3K $ | 0.00 % | as of Apr 30, 2026 ↗ |
| PROFUND VP ULTRA SMALL CAP ProFunds | 148 | 1.4K $ | 0.01 % | as of Mar 31, 2026 ↗ |
| PROFUND VP SMALL CAP ProFunds | 112 | 1K $ | 0.01 % | as of Mar 31, 2026 ↗ |
| Russell 2000 Fund Rydex Series Funds | 94 | 875.1 $ | 0.01 % | as of Mar 31, 2026 ↗ |
| SMALL-CAP PROFUND ProFunds | 81 | 718.5 $ | 0.01 % | as of Apr 30, 2026 ↗ |
| Russell 2000 1.5x Strategy Fund Rydex Series Funds | 56 | 521.4 $ | 0.01 % | as of Mar 31, 2026 ↗ |
| Columbia Research Enhanced Small Cap ETF Columbia ETF Trust I | 42 | 391 $ | 0.01 % | as of Mar 31, 2026 ↗ |
| ProShares Hedge Replication ETF ProShares Trust | 41 | 396.1 $ | 0.00 % | as of Feb 28, 2026 ↗ |
| ProShares Russell 2000 Dynamic Buffer ETF ProShares Trust | 12 | 115.9 $ | 0.01 % | as of Feb 28, 2026 ↗ |
| Russell 2000(R) 1.5x Strategy Fund Rydex Variable Trust | 11 | 102.4 $ | 0.00 % | as of Mar 31, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| Simplify Propel Opportunities ETF Simplify Exchange Traded Funds | 0.95 % | as of Mar 31, 2026 ↗ |
| Federated Hermes MDT Small Cap Value Fund f/k/a Federated Hermes Clover Small Value Fund Federated Hermes Equity Funds | 0.66 % | as of Mar 31, 2026 ↗ |
| Virtus Biotech Clinical Trials Etf ETFis Series Trust I | 0.60 % | as of Apr 30, 2026 ↗ |
| Ultra-Small Company Market Fund Bridgeway Funds, Inc. | 0.38 % | as of Mar 31, 2026 ↗ |
| Federated Hermes MDT Small Cap Core ETF Federated Hermes ETF Trust | 0.25 % | as of Feb 28, 2026 ↗ |
| Federated Hermes MDT Small Cap Core Fund Federated Hermes MDT Series | 0.22 % | as of Apr 30, 2026 ↗ |
| State Street(R) SPDR(R) S&P(R) Biotech ETF SPDR SERIES TRUST | 0.17 % | as of Mar 31, 2026 ↗ |
| PROFUND VP BIOTECHNOLOGY ProFunds | 0.16 % | as of Mar 31, 2026 ↗ |
| Janus Henderson Global Life Sciences Fund JANUS INVESTMENT FUND | 0.15 % | as of Mar 31, 2026 ↗ |
| Direxion Daily S&P Biotech Bull 3X Shares Direxion Shares ETF Trust | 0.13 % | as of Apr 30, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Shareholders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q2 | 163 | +12 | 11,816,145 | +2.9 % |
| 2026Q1 | 151 | +25 | 11,486,816 | +33.3 % |
| 2025Q4 | 126 | +8 | 8,614,203 | -6.7 % |
| 2025Q3 | 118 | -15 | 9,228,854 | -6.7 % |
| 2025Q2 | 133 | +1 | 9,894,507 | +11.3 % |
| 2025Q1 | 132 | -8 | 8,891,204 | -15.5 % |
| 2024Q4 | 140 | -14 | 10,521,249 | -1.8 % |
| 2024Q3 | 154 | -11 | 10,715,718 | -2.1 % |
| 2024Q2 | 165 | +18 | 10,944,440 | +29.1 % |
| 2024Q1 | 147 | +8 | 8,475,202 | +4.3 % |
| 2023Q4 | 139 | 8,127,888 |
Institutional managers
148 managers declare this company to the SEC (Form 13F). The table shows the 25 largest.
| Manager | Shares | Value | |
|---|---|---|---|
| JANUS HENDERSON GROUP PLC | 5,247,151 | 48.9M $ | as of Mar 31, 2026 |
| RA CAPITAL MANAGEMENT, L.P. | 5,049,779 | 47M $ | as of Mar 31, 2026 |
| GOLDMAN SACHS GROUP INC | 4,205,438 | 39.2M $ | as of Mar 31, 2026 |
| BlackRock, Inc. | 4,145,303 | 38.6M $ | as of Mar 31, 2026 |
| NOVO HOLDINGS A/S | 3,650,737 | 34M $ | as of Mar 31, 2026 |
| BVF INC/IL | 2,879,289 | 26.8M $ | as of Mar 31, 2026 |
| STATE STREET CORP | 2,707,875 | 25.2M $ | as of Mar 31, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | 2,195,578 | 20.4M $ | as of Mar 31, 2026 |
| ARMISTICE CAPITAL, LLC | 2,000,000 | 18.6M $ | as of Mar 31, 2026 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 1,605,156 | 14.9M $ | as of Mar 31, 2026 |
| FEDERATED HERMES, INC. | 1,432,260 | 13.3M $ | as of Mar 31, 2026 |
| Trails Edge Capital Partners, LP | 1,302,917 | 12.1M $ | as of Mar 31, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | 1,065,345 | 9.9M $ | as of Mar 31, 2026 |
| BANK OF AMERICA CORP /DE/ | 974,173 | 9.1M $ | as of Mar 31, 2026 |
| Evergreen Quality Fund GP, Ltd. | 951,474 | 8.9M $ | as of Mar 31, 2026 |
| DEUTSCHE BANK AG\ | 708,044 | 6.6M $ | as of Mar 31, 2026 |
| RENAISSANCE TECHNOLOGIES LLC | 578,265 | 5.4M $ | as of Mar 31, 2026 |
| Nuveen, LLC | 561,805 | 5.2M $ | as of Mar 31, 2026 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 555,829 | 5.2M $ | as of Mar 31, 2026 |
| DIMENSIONAL FUND ADVISORS LP | 522,823 | 4.9M $ | as of Mar 31, 2026 |
| Parkman Healthcare Partners LLC | 522,577 | 4.9M $ | as of Mar 31, 2026 |
| RTW INVESTMENTS, LP | 475,737 | 4.4M $ | as of Mar 31, 2026 |
| JPMORGAN CHASE & CO | 415,655 | 3.6M $ | as of Mar 31, 2026 |
| Propel Bio Management, LLC | 380,420 | 3.6M $ | as of Mar 31, 2026 |
| MORGAN STANLEY | 345,410 | 3.2M $ | as of Mar 31, 2026 |
Declared shareholders of 4D Molecular Therapeutics Inc
There are 4 beneficial ownership filings. These stakes do not add up. An asset manager that files includes its own funds, which already appear among the funds on this page.
| Shareholder | Declared stake | Shares | |
|---|---|---|---|
| JANUS HENDERSON GROUP PLC | 10.30 % | 5,247,151 | as of Mar 31, 2026 · SCHEDULE 13G |
| BIOTECHNOLOGY VALUE FUND L P and 9 others | 9.99 % | 5,346,519 | as of Mar 31, 2026 · SCHEDULE 13G |
| RA Capital Management, L.P. and 3 others | 9.90 % | 5,105,622 | as of Mar 31, 2026 · SCHEDULE 13G |
| STATE STREET CORPORATION | 5.30 % | 2,707,875 | as of Mar 31, 2026 · SCHEDULE 13G |
Cite this page
Titelia. "Fund shareholders of 4D Molecular Therapeutics Inc". https://titelia.com/en/stocks/4d-molecular-therapeutics-inc-US35104E1001